TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ATYR

aTyr Pharma, Inc.

Healthcare · Biotechnology

0.3728$ +2.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

aTyr Pharma, Inc. (ATYR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ATYR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-23 -37 -53 -42 -31 -20 -15 -33 -42 -33 -69 -62
0.8 0.9 0.9 0.7 0.7 1.4 1.3 1.3 1.7 2.7 1.5 1.6
1.8 4.9 1.8 1.5 1.6 2.2 2.6 3.0 5.0
-1.3 3.3 -1.4 -1.7 -1.4 0.2 -2.3 -2.6 -0.8 15 -6.9 7.5
0.2 0.7 0.6 1.3 0.6 0.1 0.2 0.2 1.6 4.2 0.1 0.1
-2.2 -72 34 -28 37 4.9 6.9 -92 47 -20 17 -5.1
0.0 -0.1 -0.4 -0.5 -0.5
2.5 148 4.7 53 -4.2 1.3 16 110 5.5 66 40 66
-23 39 -15 -17 1.9 -14 7.7 -15 11 13 -12 -1.0
-23 -37 -53 -44 -32 -20 -16 -33 -44 -37 -69 -62

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?